Innovative Tech (523840)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹36.33 |
| Market Cap | ₹83.83 Cr |
| P/E Ratio | 0 |
| ROCE | 6.5% |
| ROE | -4.65% |
| Dividend Yield | 0% |
| Profit Growth | 413.64% |
| Debt/Equity | — |
| Sales Growth | 4.57% |
| 52-Week Range | ₹12.75 — ₹36.33 |
| Sector | Industrial Products |
| Book Value | ₹19.94 |
Strengths
- Piotroski F-Score of 7/9 suggests improving fundamentals
- Latest quarter turned profitable with ₹1 Cr net profit on ₹32 Cr sales
- Sales growth is positive at 4.57%
- ROCE of 6.50% is positive, showing some operational return
- Book value of ₹19.94 provides a measurable asset base
Concerns
- Return on equity is negative at -4.65%, eroding shareholder value
- P/E is effectively zero or not meaningful due to inadequate earnings
- No dividend yield, so there is no income support for shareholders
- Promoter holding and debt/equity data are unavailable, raising transparency concerns
AI Analysis
This is the kind of tiny packaging business I would normally spend a long time understanding before reaching for my wallet. With a market cap of ₹84 Cr and a share price of ₹36.33, I have to ask what I am really buying. Book value is ₹19.94, so at 1.82 times book I am paying a healthy premium for a business whose return on equity is negative 4.65%. That is not a formula for compounding value. The latest quarter shows sales of ₹32 Cr and a small net profit of ₹1 Cr, which is encouraging, but one good quarter does not make a turnaround. The 413.64% profit growth looks eye-catching, but it is meaningless from a weak base. Sales growth of only 4.57% tells me this is not a fast grower. On the positive side, the Piotroski F-score of 7 out of 9 is a solid sign of improving financial health, and ROCE of 6.50% is at least positive, though not exciting. I see no dividend yield, so patience gets no income while waiting. The stock is at its 52-week high of ₹36.33, meaning the market has already bid it up from ₹12.75; any easy money has been made. Debt/equity is not available, and promoter holding is not available, which bothers me. I cannot evaluate management skin in the game or balance sheet risk properly. A packaging company with a tiny market cap, modest growth, and unclear governance is not a classic Graham bargain. If earnings can be sustained and ROE turns positive, perhaps it becomes a small turnaround at a reasonable price. Until then, I would watch from the sidelines. Capital preservation matters more than chasing a 4.57% grower at 1.82 times book.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer